BACKGROUND: Misoprostol is a prostaglandin E1 analogue that has been used for medical
abortion. We conducted this prospective study to compare the efficacy of vaginal misoprostol …

Objectives To evaluate whether the regimen of oral mifepristone and misoprostol for medical
abortion is acceptable to women and providers, in the United States, including physicians …

Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …

BACKGROUND Home use of misoprostol for termination of pregnancy is still controversial in
many countries. Acceptability of home use of misoprostol has been investigated in …

Objective To assess differences in outcomes of misoprostol with or without mifepristone for
second-trimester abortion. Methods A randomized, double-blind, placebo-controlled trial of …

Objective The aim of this study was to report on the safety and efficacy of an evidence-based
medical abortion regimen utilizing 200 mg of mifepristone orally followed by home use of …

Increased access to medical methods of abortion could significantly reduce maternal
mortality, especially in developing countries. In light of the political and commercial …

Objective: Because of concern over the higher rates of failed abortion, many clinicians defer
surgical abortion until 7 menstrual weeks or later. We conducted this study to evaluate the …

OBJECTIVE: To compare the efficacy of the vaginal and sublingual administration of the
synthetic prostaglandin misoprostol with the currently used oral administration route in …

Objective To determine the efficacy of oral mifepristone followed by vaginal misoprostol 6
hours later compared with the standard 36‐to 48‐hour regimen for medical termination of …